BAYnovation, the randomized clinical trial of a group of 450 patients with adenoviral conjunctivitis, will study the efficacy of the treatment that is the first of its kind worldwide.
The clinical results of BAYnovation are expected in late 2013.
More Articles on Ophthalmology:
Arizona Aiello Eye Institute Expands Services to Foothills Location
LENSAR Laser System Earns FDA 510(k) Clearance
IRIDEX, Peregrine Surgical Partner
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
